Mathias Loberg Haarhaus

Publications
Public outreach and news

Articles

Journal article: RENAL FAILURE. 2024;46(1):2313170
Early referral to nephrological care improves long-term survival and hospitalization after dialysis initiation, independent of optimal dialysis start – a call for harmonization of reimbursement policies
Haarhaus M; Bratescu LO; Pana N; Gemene EM; Silva EM; Araujo CARS; Macario F
Article: RENAL FAILURE. 2024;46(1):2313170
Early referral to nephrological care improves long-term survival and hospitalization after dialysis initiation, independent of optimal dialysis start - a call for harmonization of reimbursement policies.
Haarhaus M; Bratescu LO; Pana N; Gemene EM; Silva EM; Santos Araujo CAR; Macario F
Article: JBMR PLUS. 2024;8(2):ziae006
Glycoproteomic profile of human tissue-nonspecific alkaline phosphatase expressed in osteoblasts
Atanasova D; Mirgorodskaya E; Moparthi L; Koch S; Haarhaus M; Narisawa S; Millan JL; Landberg E; Magnusson P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024;39(2):341-366
Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement
Evenepoel P; Jorgensen HS; Bover J; Davenport A; Bacchetta J; Haarhaus M; Hansen D; Gracia-Iguacel C; Ketteler M; McAlister L; White E; Mazzaferro S; Vervloet M; Shroff R
Article: CKJ: CLINICAL KIDNEY JOURNAL. 2024;17(1):sfad276
Klotho: a potential therapeutic target in aging and neurodegeneration beyond chronic kidney disease-a comprehensive review from the ERA CKD-MBD working group
Kanbay M; Copur S; Ozbek L; Mutlu A; Cejka D; Ciceri P; Cozzolino M; Haarhaus ML
Article: CKJ: CLINICAL KIDNEY JOURNAL. 2024;17(1):sfad290
Real-world usage of Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD) biomarkers in nephrology practices.
Fusaro M; Barbuto S; Gallieni M; Cossettini A; Re Sartò GV; Cosmai L; Cianciolo G; La Manna G; Nickolas T; Ferrari S; Bover J; Haarhaus M; Marino C; Mereu MC; Ravera M; Plebani M; Zaninotto M; Cozzolino M; Bianchi S; Messa P; Gregorini M; Gasperoni L; Agosto C; Aghi A; Tripepi G
Article: NUTRIENTS. 2023;15(3):598
Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
Huybrechts Y; Evenepoel P; Haarhaus M; Cavalier E; Dams G; Van Hul W; D'Haese PCC; Verhulst A
Article: ACTA MEDICA LITUANICA. 2023;30(1):26-38
Waning Humoral Response 6 Month after Double Vaccination with the mRNA-BNT162b2 Vaccine in Hemodialysis Patients
Balciuviene V; Burciuviene A; Haarhaus M; Uogintaite J; Janaviciene A; Santockiene L; Mitrikeviciene J; Alekniene L; Keinaite D
Article: JOURNAL OF NEPHROLOGY. 2022;35(5):1467-1478
Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients
Haase M; Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos-Araujo C; Veiga PM; Macario F
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;95(5):e13152
Improved immunologic response to COVID-19 vaccine with prolonged dosing interval in haemodialysis patients
Haarhaus M; Duhanes M; Lesevic N; Matei B; Ramsauer B; Rodrigues RDS; Su J; Haase M; Santos-Araujo C; Macario F
Article: SEMINARS IN DIALYSIS. 2022;35(3):269-277
Immunogenicity and tolerability of COVID-19 vaccination in peritoneal dialysis patients-A prospective observational cohort study
Haase M; Lesny P; Haase-Fielitz A; Anderson M; Cloherty G; Stec M; Lucas C; Santos-Araujo C; Haarhaus M; Macario F
Journal article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(2):375-381
Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in haemodialysis patients: a multicentre study
Santos-Araújo C; Veiga PM; Santos MJ; Santos L; Romãozinho C; Silva M; Lucas C; Duarte ML; Haarhaus M; Haase M; Macário F
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37(2):375-381
Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in haemodialysis patients: a multicentre study.
Santos-Araújo C; Mota Veiga P; Santos MJ; Santos L; Romãozinho C; Silva M; Lucas C; Duarte ML; Haarhaus M; Haase M; Macário F
Article: NUTRIENTS. 2021;13(12):4402
The Novel Bone Alkaline Phosphatase Isoform B1x Is Associated with Improved 5-Year Survival in Chronic Kidney Disease
Haarhaus M; Fernstrom A; Qureshi AR; Magnusson P
Article: JOURNAL OF NEPHROLOGY. 2021;34(4):975-983
Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study
Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos C; Lucas C; Macario F; Haase M
Article: CKJ: CLINICAL KIDNEY JOURNAL. 2021;14(3):805-813
Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings
Haarhaus M; Santos C; Haase M; Veiga PM; Lucas C; Macario F
Article: PERITONEAL DIALYSIS INTERNATIONAL. 2021;41(2):236-243
High alkaline phosphatase and low intact parathyroid hormone associate with worse clinical outcome in peritoneal dialysis patients
Chen Z; Zhang X; Han F; Xie X; Hua Z; Huang X; Lindholm B; Haarhaus M; Stenvinkel P; Qureshi AR; Chen J
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021;36(3):413-425
Bone evaluation in paediatric chronic kidney disease: clinical practice points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis working groups and CKD-MBD working group of the ERA-EDTA.
Bakkaloglu SA; Bacchetta J; Lalayiannis AD; Leifheit-Nestler M; Stabouli S; Haarhaus M; Reusz G; Groothoff J; Schmitt CP; Evenepoel P; Shroff R; Haffner D; European Society for Paediatric Nephrology (ESPN)
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2021;36(1):42-59
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4-G5D
Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust M-H; Prieto-Alhambra D; Torres PU; Cannata-Andia J
Article: CLINICA CHIMICA ACTA. 2020;501:198-206
Bone alkaline phosphatase: An important biomarker in chronic kidney disease - mineral and bone disorder
Nizet A; Cavalier E; Stenvinkel P; Haarhaus M; Magnusson P
Article: ATHEROSCLEROSIS. 2019;290:59-65
Apabetalone lowers serum alkaline phosphatase and improves cardiovascular risk in patients with cardiovascular disease
Mathias H; Ray KK; Nicholls SJ; Schwartz GG; Kulikowski E; Johansson JO; Sweeney M; Halliday C; Lebioda K; Wong N; Brandenburg V; Beddhu S; Tonelli M; Zoccali C; Kalantar-Zadeh K
Article: BMC NEPHROLOGY. 2019;20(1):59
Differences in association of lower bone mineral density with higher coronary calcification in female and male end-stage renal disease patients
Chen Z; Qureshi AR; Brismar TB; Ripsweden J; Haarhaus M; Barany P; Heimburger O; Lindholm B; Stenvinkel P
Article: CALCIFIED TISSUE INTERNATIONAL. 2019;104(2):214-223
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Boltenstal H; Qureshi AR; Behets GJ; Lindholm B; Stenvinkel P; D'Haese PC; Haarhaus M
Article: KIDNEY & BLOOD PRESSURE RESEARCH. 2018;43(2):449-457
Apabetalone Mediated Epigenetic Modulation is Associated with Favorable Kidney Function and Alkaline Phosphatase Profile in Patients with Chronic Kidney Disease
Kulikowski E; Halliday C; Johansson J; Sweeney M; Lebioda K; Wong N; Haarhaus M; Brandenburg V; Beddhu S; Tonelli M; Zoccali C; Kalantar-Zadeh K
Article: JOURNAL OF BONE AND MINERAL METABOLISM. 2017;35(5):536-543
Bone mineral density of extremities is associated with coronary calcification and biopsy-verified vascular calcification in living-donor renal transplant recipients
Chen Z; Sun J; Haarhaus M; Barany P; Wennberg L; Ripsweden J; Brismar TB; Lindholm B; Wernerson A; Soderberg M; Stenvinkel P; Qureshi AR
Article: KIDNEY INTERNATIONAL REPORTS. 2017;2(3):481-485
Sclerostine-A Debutant on the Autosomal Dominant Polycystic Kidney Disease Scene?
Jankowska M; Haarhaus M; Qureshi AR; Lindholm B; Evenepoel P; Stenvinkel P
Article: JOURNAL OF NEPHROLOGY. 2017;30(2):255-262
Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis
Bergman A; Qureshi AR; Haarhaus M; Lindholm B; Barany P; Heimburger O; Stenvinkel P; Anderstam B
Article: BONE. 2016;92:50-57
Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients
Chen Z; Qureshi AR; Ripsweden J; Wennberg L; Heimburger O; Lindholm B; Barany P; Haarhaus M; Brismar TB; Stenvinkel P
Article: KIDNEY INTERNATIONAL. 2015;88(6):1356-1364
Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Qureshi AR; Olauson H; Witasp A; Haarhaus M; Brandenburg V; Wernerson A; Lindholm B; Soderberg M; Wennberg L; Nordfors L; Ripsweden J; Barany P; Stenvinkel P
Article: AMERICAN JOURNAL OF KIDNEY DISEASES. 2015;66(1):99-105
Bone Alkaline Phosphatase Isoforms in Hemodialysis Patients With Low Versus Non-Low Bone Turnover: A Diagnostic Test Study
Haarhaus M; Monier-Faugere M-C; Magnusson P; Malluche HH
Article: RENAL FAILURE. 2013;35(6):845-854
A fixed protocol for outpatient clinic routines in the care of patients with severe renal failure
Hadimeri H; Frisenette-Fich C; Deurell S-I; Svensson L; Carlsson-Bjering L; Fernstrom A; Almroth G; Melander S; Haarhaus M; Andersson P-O; Cassel A; Mauritz N-J; Stahl-Nilsson A; Wilske J; Nordstrom K; Oruda P; Eriksson M; Larsson AI; Stegmayr B
Article: JOURNAL OF VASCULAR RESEARCH. 2013;50(2):167-174
Calcifying Human Aortic Smooth Muscle Cells Express Different Bone Alkaline Phosphatase Isoforms, Including the Novel B1x Isoform
Haarhaus M; Arnqvist HJ; Magnusson P
Article: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2009;24(11):3382-3389
Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease
Haarhaus M; Fernstrom A; Magnusson M; Magnusson P
Article: NEOPLASMA. 2004;51(1):1-11
Inhibition of puromycin-induced apoptosis in breast cancer cells by IGF-I occurs simultaneously with increased protein synthesis
Söderlund G; Haarhaus M; Chisalita S; Arnqvist HJ
Article: MEDIZINISCHE AUSBILDUNG. 1998;15:65-69
Der Modified Essay Question(MEQ)- Test an der medizinischen Fakultät der Universität Wittenf Herdecke
Wildt D; Rützler M; Haarhaus M; Peters K; Loberg Haarhaus M
Show more

All other publications

Review: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2024;39(10):1574-1582
Klotho in pregnancy and intrauterine development-potential clinical implications: a review from the European Renal Association CKD-MBD Working Group
Kanbay M; Mutlu A; Bakir CN; Peltek IB; Canbaz AA; Diaz Tocados JM; Haarhaus M
Review: JOURNAL OF CLINICAL MEDICINE. 2024;13(4):1010
Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter
Lloret MJ; Fusaro M; Jorgensen HS; Haarhaus M; Gifre L; Alfieri CM; Masso E; D'Marco L; Evenepoel P; Bover J
Review: CKJ: CLINICAL KIDNEY JOURNAL. 2024;17(2):sfae023
Management of de novo nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group
Kanbay M; Copur S; Bakir CN; Hatipoglu A; Sinha S; Haarhaus M
Review: CKJ: CLINICAL KIDNEY JOURNAL. 2023;16(3):456-472
Management of fracture risk in CKD-traditional and novel approaches
Haarhaus M; Aaltonen L; Cejka D; Cozzolino M; de Jong RT; D'Haese P; Evenepoel P; Lafage-Proust M-H; Mazzaferro S; McCloskey E; Salam S; Jorgensen HS; Vervloet M
Letter: KIDNEY INTERNATIONAL. 2022;102(2):431-434
Bone histomorphometry for the diagnosis of renal osteodystrophy: a call for harmonization of reference ranges
Jorgensen HS; Ferreira AC; D'Haese P; Haarhaus M; Vervloet M; Lafage-Proust M-H; Ferreira A; Evenepoel P
Review: NUTRIENTS. 2022;14(10):2124
Alkaline Phosphatase: An Old Friend as Treatment Target for Cardiovascular and Mineral Bone Disorders in Chronic Kidney Disease
Haarhaus M; Cianciolo G; Barbuto S; La Manna G; Gasperoni L; Tripepi G; Plebani M; Fusaro M; Magnusson P
Meeting abstract: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2022;37:I851
IMPROVED IMMUNOLOGIC RESPONSE TO COVID-19 VACCINE WITH PROLONGED DOSING INTERVAL IN HEMODIALYSIS PATIENTS
Haarhaus M; Duhanes M; Lesevic N; Matei B; Ramsauer B; Rodrigues RDS; Su J; Haase M; Santos C; Macario F
Review: OSTEOPOROSIS INTERNATIONAL. 2021;32(12):2397-2405
Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism
Evenepoel P; Cunningham J; Ferrari S; Haarhaus M; Javaid MK; Lafage-Proust MH; Prieto-Alhambra D; Torres PU; Cannata-Andia J
Review: KIDNEY INTERNATIONAL. 2021;100(3):546-558
Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment
Haarhaus M; Evenepoel P
Letter: KIDNEY INTERNATIONAL. 2020;98(5):1352-1353
English-Latin nomenclature conundrum: should we use kidneylogy, kidneylogist?
Bover J; Haarhaus ML; Furlano M; Urena P; Vervloet M; daSilva I; Brandenburg V; Garcia-Maset R; Bellasi A; Tesar V
Review: CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2020;29(1):4-15
Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease
Haarhaus M; Gilham D; Kulikowski E; Magnusson P; Kalantar-Zadeh K
Review: NEPHROLOGY DIALYSIS TRANSPLANTATION. 2017;32(10):1608-1613
Bone biopsy practice patterns across Europe: the European renal osteodystrophy initiative-a position paper
Evenepoel P; D'Haese P; Bacchetta J; Cannata-Andia J; Ferreira A; Haarhaus M; Mazzaferro S; Lafage Proust M-H; Salam S; Spasovski G; Cozzolino M
Review: NATURE REVIEWS NEPHROLOGY. 2017;13(7):429-442
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD
Haarhaus M; Brandenburg V; Kalantar-Zadeh K; Stenvinkel P; Magnusson P
Letter: CLINICAL CHEMISTRY. 2006;52(5):903-904
Comparison of 3 third-generation assays for bio-intact parathyroid hormone
Ljungdahl N; Haarhaus M; Linder C; Magnusson P

Articles

All other publications

News from KI

Events from KI